![2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]- N -(2,3-dihydro-2-oxo-1 H -benzimidazol-5-yl)-3-oxobutanamide KAYACEL YELLOW CG; NO.466 BZN 611-041-00-4 structure](https://www.ebi.ac.uk/opsin/ws/2-%5B%5B4%5B%5B4%2C6-bis%5B%5B3-(diethylamino)propyl%5Damino%5D-1%2C3%2C5-triazine-2-yl%5Damino%5Dphenyl%5Dazo%5D-%20N%20-(2%2C3-dihydro-2-oxo-1%20H%20-benzimidazol-5-yl)-3-oxobutanamide%20KAYACEL%20YELLOW%20CG%3B%20NO.466%20BZN%20611-041-00-4.png)
2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]- N -(2,3-dihydro-2-oxo-1 H -benzimidazol-5-yl)-3-oxobutanamide KAYACEL YELLOW CG; NO.466 BZN 611-041-00-4
Name
2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]- N -(2,3-dihydro-2-oxo-1 H -benzimidazol-5-yl)-3-oxobutanamide KAYACEL YELLOW CG; NO.466 BZN 611-041-00-4
Molecular Formula
C34H49N13O3
Identifiers
cas number98809-11-1PRIMARY
ec number407-680-1
chemical name2-[[4-[[4,6-bis[[3-(diethylamino) propyl]amino]-1,3,5-triazin-2-yl]amino]phenyl] azo]-N-(2,3-dihydroButanamide
chemical name2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]- N -(2,3-dihydro-2-oxo-1 H -benzimidazol-5-yl)-3-oxobutanamide KAYACEL YELLOW CG; NO.466 BZN 611-041-00-4
GHS Hazard Pictograms
GHS09
GHS05
GHS07Hazard Classifications
Eye Dam. 1
Danger
Serious eye damage
Hazard Code:H318
Category:Eye Dam. 1
Source: Harmonised C&L
Skin Sens. 1
Warning
Skin sensitisation
Hazard Code:H317
Category:Skin Sens. 1
Source: Harmonised C&L
Aquatic Chronic 2
Hazardous to the aquatic environment (long-term)
Hazard Code:H411
Category:Aquatic Chronic 2
Source: Harmonised C&L
Regulatory Lists (2)
CLP ANNEX VI — HARMONISED CLASSIFICATION AND LABELLING
Substances with a harmonised classification and labelling in Annex VI of the CLP Regulation (EC) No 1272/2008. The classification is legally binding across the EU and overrides a supplier's own self-classification.
KEMI PRIO PHASE-OUT SUBSTANCES
KEMI PRIO Phase-Out Substances — Swedish Chemicals Agency list of substances with properties of very high concern that should be phased out
Disclaimer
The substance data provided is sourced from various third-party databases and regulatory sources. While we strive to maintain accuracy, we cannot guarantee the completeness, accuracy, or timeliness of this information. Users are responsible for verifying all data before use in compliance, safety, or regulatory contexts. NextSDS is not liable for any decisions made based on this data.